# bNovate Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bnovate-technologies

- Industry: Biotechnology
- Headquarters: Switzerland
- Website: www.bnovate.com
- Total disclosed funding: $13M
- Latest round: Series C (Jun 20, 2023)
- Investors on record: 1

## About

Based in Ecublens, Switzerland, and founded in 2011, bNovate Technologies SA provides fully automated analysis instruments. The company is based at the Innovation Park of the Swiss Federal Institute of Technology of Lausanne (EPFL). They started their activities with a few people focused on innovation. Presently, bNovate Technologies SA has grown into a strong team of scientific experts and managers who can address the challenge of developing the most demanding, fully automated analysis instruments. In 2020 they established a marketing and sales department in Zurich In order to get closer to their users. In June 2023, bNovate Technologies SA raised CHF 12 million in series C funding led by Emerald Technology Ventures.

bNovate Technologies SA specialized in Online Monitoring, Flow Cytometry, Biology, Microbiology, Total Cell Count, Automated Flow Cytometer, Flow Cytometer, Rapid Microbiological Monitoring, Pure Water, WFI, Water, Drinking Water, Bottled Water, Automated Flow Cytometry, Automated Flow Cytometer, Food and Beverage, Water, Water Safety, Rapid Microbiology, Water Treatment, and Water Analysis. With its fully automated solution, bNovate Technologies SA has digitalized and simplified the measurement of bacteria in water. The company's customers include several cities in Europe, as well as multinationals in the pharmaceutical and food & beverage sectors.

## Funding rounds

- Series C, Jun 20, 2023, $13M — Emerald Technology Ventures

## Investors

- Emerald Technology Ventures (https://capitalatlas.ai/funds/emerald-technology-ventures) — Series C